These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9222050)

  • 1. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
    Soman A; Honeybourne D; Andrews J; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Dec; 44(6):835-8. PubMed ID: 10590288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Jevons G; Brenwald NP; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Oct; 40(4):573-7. PubMed ID: 9372428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Banerjee D; Andrews J; Wise R
    J Antimicrob Chemother; 2001 Jul; 48(1):63-6. PubMed ID: 11418513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung concentrations of telithromycin after oral dosing.
    Khair OA; Andrews JM; Honeybourne D; Jevons G; Vacheron F; Wise R
    J Antimicrob Chemother; 2001 Jun; 47(6):837-40. PubMed ID: 11389116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
    Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
    J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.
    Ziglam HM; Baldwin DR; Daniels I; Andrew JM; Finch RG
    J Antimicrob Chemother; 2002 Dec; 50(6):1011-5. PubMed ID: 12461025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
    Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
    J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J; Teng R; Dalvie DK; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
    Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.